These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21235)

  • 1. A comparison of the dissolution rates of caffeine tablets in a rotating-basket with those in a Sartorius dissolution tester.
    Kitazawa S; Johno I; Minouchi T; Ito Y; Okada J
    J Pharm Pharmacol; 1977 Oct; 29(10):585-8. PubMed ID: 21235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hardness on the disintegration time and the dissolution rate of uncoated caffeine tablets.
    Kitazawa S; Johno I; Ito Y; Teramura S; Okado J
    J Pharm Pharmacol; 1975 Oct; 27(10):765-70. PubMed ID: 241790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation of dissolution rate data from in vitro testing of compressed tablets.
    Kitazawa S; Johno I; Minouchi T; Okada J
    J Pharm Pharmacol; 1977 Aug; 29(8):453-9. PubMed ID: 19592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dissolution determination in the rotating flask model. Effect of rotation rate and fluid volume on the solubility determination of standard test tablets in the Resotest dissolution tester].
    Koch HP; Pfeifer G
    Pharmazie; 1983 May; 38(5):318-23. PubMed ID: 6611628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies on eight dissolution method using 21 commercial chloramphenicol tablets and a nondisintegrating benzoic acid tablet.
    Ogata H; Shibazaki T; Inoue T; Ejima A
    J Pharm Sci; 1979 Jun; 68(6):708-12. PubMed ID: 458569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bioavailability of diazepam from uncoated tablets in humans--Part I: correlation with the dissolution rates of the tablets.
    Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Tsuji S; Kawazu Y
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):159-65. PubMed ID: 7076345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of in vitro test conditions on release of aspirin from commercial tablets.
    Nikolić L; Djurić Z; Jovanović M
    J Pharm Sci; 1992 Apr; 81(4):386-91. PubMed ID: 1501078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two dissolution apparatuses: rotating basket versus rotating flask.
    Koch HP; Alcorn G; Ritschel WA
    Pharmazie; 1983 Apr; 38(4):233-5. PubMed ID: 6867085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time and temperature dependence of disintegration and correlation between dissolution and disintegration rate constants.
    Carstensen JT; Kothari R; Prasad VK; Sheridan J
    J Pharm Sci; 1980 Mar; 69(3):290-4. PubMed ID: 7381704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of paracetamol-caffeine co-crystals to improve compressional, formulation and in vivo performance.
    Latif S; Abbas N; Hussain A; Arshad MS; Bukhari NI; Afzal H; Riffat S; Ahmad Z
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1099-1108. PubMed ID: 29385849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of operational characteristics of different dissolution testing systems.
    Hardwidge EA; Sarapu AC; Laughlin WC
    J Pharm Sci; 1978 Dec; 67(12):1732-5. PubMed ID: 722490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of solid dispersion technique in the preparation of therapeutic tablets. Part 1: Paracetamol, amylobarbitone, and caffeine tablets.
    El-Banna HM; Eshra AG; Hammouda Y
    Pharmazie; 1977; 32(8-9):511-5. PubMed ID: 145597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the polymorphism of Barbiturates in powers and tablets. Part 5: The dissolution of recrystallized barbital substances and their release from tablet (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Feb; 35(2):95-8. PubMed ID: 7384189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New in vitro dissolution test apparatus.
    Nasir SS; Wilken LO; Nasir SM
    J Pharm Sci; 1979 Feb; 68(2):177-81. PubMed ID: 423087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR; Paim CS; Steppe M; Schapoval EE
    J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. USP dissolution III: semilogarithmic dissolution patterns of tablets in rotating-basket assemblies.
    Carstensen JT; Wright JL; Blessel K; Sheridan J
    J Pharm Sci; 1978 Jul; 67(7):982-4. PubMed ID: 660522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.